ResearcherAmsterdam University Medical CentersNo recent work listed
Giovanna Li Petri
Matched on ORCID iD 0000-0001-6113-5978; OpenAlex author ID A5075852389. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2019: 2 papers · 2020: 2 papers
Papers 4
- Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells. First author DOI 10.1016/j.ejmech.2020.112088↗
- 3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/molecules25020329↗
- Pharmacogenetics of treatments for pancreatic cancer. First author DOI 10.1080/17425255.2019.1620731↗
- Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3,4]thiadiazol-2-yl)-1H-indole Derivative… Co-author DOI 10.21873/anticanres.13509↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stella Cascioferro · 4 shared papers, 2019–2020 · strength 0.39
- Paper Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic… DOI 10.1016/j.ejmech.2020.112088↗
- Paper 3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pa… DOI 10.3390/molecules25020329↗
- Paper Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3… DOI 10.21873/anticanres.13509↗
- Barbara Parrino · 4 shared papers, 2019–2020 · strength 0.39
- Paper Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic… DOI 10.1016/j.ejmech.2020.112088↗
- Paper 3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pa… DOI 10.3390/molecules25020329↗
- Paper Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3… DOI 10.21873/anticanres.13509↗
- Elisa Giovannetti · 4 shared papers, 2019–2020 · strength 0.39
- Paper Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic… DOI 10.1016/j.ejmech.2020.112088↗
- Paper 3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pa… DOI 10.3390/molecules25020329↗
- Paper Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3… DOI 10.21873/anticanres.13509↗
- Patrizia Diana · 4 shared papers, 2019–2020 · strength 0.39
- Paper Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic… DOI 10.1016/j.ejmech.2020.112088↗
- Paper 3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pa… DOI 10.3390/molecules25020329↗
- Paper Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3… DOI 10.21873/anticanres.13509↗
- Daniela Carbone · 3 shared papers, 2019–2020 · strength 0.29
- Paper Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic… DOI 10.1016/j.ejmech.2020.112088↗
- Paper 3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pa… DOI 10.3390/molecules25020329↗
- Paper Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3… DOI 10.21873/anticanres.13509↗
- Godefridus J. Peters · 3 shared papers, 2019–2020 · strength 0.29
- Paper Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic… DOI 10.1016/j.ejmech.2020.112088↗
- Paper 3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pa… DOI 10.3390/molecules25020329↗
- Paper Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3… DOI 10.21873/anticanres.13509↗
- Btissame El Hassouni · 3 shared papers, 2019–2020 · strength 0.29
- Paper 3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pa… DOI 10.3390/molecules25020329↗
- Paper Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3… DOI 10.21873/anticanres.13509↗
- Paper Pharmacogenetics of treatments for pancreatic cancer. DOI 10.1080/17425255.2019.1620731↗
- Niccola Funel · 2 shared papers, 2020 · strength 0.20
- Paper Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic… DOI 10.1016/j.ejmech.2020.112088↗
- Paper 3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pa… DOI 10.3390/molecules25020329↗
- Cecilia Bergonzini · 1 shared paper, 2020 · strength 0.10
- Asif Ali · 1 shared paper, 2019 · strength 0.09
- Daniel Liu · 1 shared paper, 2019 · strength 0.09
- Adam Enver Frampton · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.